Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.100
-0.140 (-11.29%)
At close: Apr 1, 2025, 4:00 PM
1.150
+0.050 (4.55%)
After-hours: Apr 1, 2025, 4:05 PM EDT

Akari Therapeutics, Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
271835717137
Upgrade
Market Cap Growth
76.39%-49.58%-51.00%0.31%93.59%48.15%
Upgrade
Enterprise Value
291027585930
Upgrade
Last Close Price
1.243.129.4030.0037.0035.00
Upgrade
PB Ratio
-4.53-77.0219.5312.857.594838.79
Upgrade
P/TBV Ratio
--19.7212.917.61-
Upgrade
Debt / Equity Ratio
-0.15-----
Upgrade
Quick Ratio
0.240.841.101.542.690.89
Upgrade
Current Ratio
0.290.951.151.912.791.00
Upgrade
Return on Equity (ROE)
--1281.43%-483.23%-233.27%-363.75%-1080.27%
Upgrade
Return on Assets (ROA)
--115.51%-113.26%-81.96%-106.60%-146.14%
Upgrade
Return on Capital (ROIC)
--1344.91%-392.89%-144.04%-239.31%-679.86%
Upgrade
Earnings Yield
-66.46%-56.74%-50.73%-24.40%-24.00%-45.82%
Upgrade
FCF Yield
-48.92%-93.17%-61.47%-26.40%-23.82%-35.14%
Upgrade
Buyback Yield / Dilution
-76.18%-56.79%-45.46%-35.87%-72.53%-18.87%
Upgrade
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q